These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 15227508)

  • 1. Is thrombolysis alone the best therapy for acute myocardial infarction? Current status and emerging strategies.
    Golino P; Willerson JT
    Tex Heart Inst J; 1991; 18(1):50-61. PubMed ID: 15227508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolytic therapy: enhancement by platelet and platelet-derived mediator antagonists.
    Willerson JT; Golino P; McNatt J; Eidt J; Yao SK; Buja LM
    Mol Biol Med; 1991 Apr; 8(2):235-43. PubMed ID: 1806765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of new antiplatelet agents as adjunctive therapies in thrombolysis.
    Willerson JT; Golino P; McNatt J; Eidt J; Yao SK; Buja LM
    Am J Cardiol; 1991 Jan; 67(3):12A-18A. PubMed ID: 1990781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to the prevention of thrombotic restenosis after angioplasty or thrombolysis.
    Golino P; Chiariello M
    J Cardiovasc Pharmacol; 1991; 17 Suppl 5():S41-7. PubMed ID: 1717772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thrombolytic therapy of acute myocardial infarct--current status and new developments].
    Bode C; Schuler G; von Hodenberg E; Nordt T; Kübler W
    Z Gesamte Inn Med; 1993; 48(6-7):304-15. PubMed ID: 8333227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of prehospital thrombolytic therapy in ST-segment elevation acute coronary syndrome (<12 hours).
    Goldstein P; Wiel E
    Minerva Anestesiol; 2005 Jun; 71(6):297-302. PubMed ID: 15886591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The possible limits of thrombolysis: reocclusion and reperfusion damage].
    Ambrosio G; Golino P; Chiariello M
    Cardiologia; 1991 Dec; 36(12 Suppl 1):421-33. PubMed ID: 1841798
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percutaneous transluminal coronary angioplasty for acute myocardial infarction.
    Rothbaum DA; Hodes ZI; Linnemeier TJ; Landin RJ; Ball MW
    Cardiol Clin; 1989 Nov; 7(4):837-51. PubMed ID: 2688885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reocclusion after thrombolytic therapy: strategies for inhibiting thrombin-induced platelet aggregation.
    Puri RN; Colman RW
    Blood Coagul Fibrinolysis; 1993 Jun; 4(3):465-78. PubMed ID: 8329574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptokinase and rt-PA activate platelets by a different way: implications on the rethrombosis rate after their administration in myocardial infarction.
    Parise P; Hauert J; Iorio A; Callegari P; Agnelli G
    J Lab Clin Med; 1995 Feb; 125(2):212-21. PubMed ID: 7531212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombolysis in acute myocardial infarct].
    Erne P
    Ther Umsch; 1991 Aug; 48(8):527-34. PubMed ID: 1926013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombolytic therapy in acute myocardial infarction.
    Woo KS; White HD
    Curr Opin Cardiol; 1994 Jul; 9(4):471-82. PubMed ID: 7919592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to limit reinfarction and ischemia after thrombolytic therapy.
    Senerchia C
    Crit Care Nurs Clin North Am; 1990 Dec; 2(4):635-42. PubMed ID: 2096868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial permeability, objective of thrombolytic therapy].
    Bassand JP; Schiele F; Bernard Y; Anguenot T
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):677-87. PubMed ID: 1530409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [t-PA in thrombolytic therapy of acute myocardial infarct].
    Rutsch W; Schmutzler H
    Herz; 1994 Dec; 19(6):336-52. PubMed ID: 7843690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of heparin, aspirin and a synthetic platelet glycoprotein IIb-IIIa receptor antagonist (Ro 43-5054) on coronary artery reperfusion and reocclusion after thrombolysis with tissue-type plasminogen activator in the dog.
    Roux SP; Tschopp TB; Kuhn H; Steiner B; Hadváry P
    J Pharmacol Exp Ther; 1993 Jan; 264(1):501-8. PubMed ID: 8423548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjunctive therapy in thrombolysis for acute myocardial infarction.
    Bleich SD; Rolston WA; Tilton GD; Mailander L
    Z Kardiol; 1993; 82 Suppl 2():179-82. PubMed ID: 8328199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The management of postthrombolysis patients].
    Branzi A; Melandri G; Galié N
    Cardiologia; 1991 Dec; 36(12 Suppl 1):413-9. PubMed ID: 1688159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive pharmacologic therapy for acute myocardial infarction.
    Pepine CJ
    Clin Cardiol; 1994 Jan; 17(1 Suppl 1):I10-4. PubMed ID: 7908862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet activation during thrombolysis and percutaneous transluminal coronary angioplasty in the acute phase of myocardial infarction].
    Abe S; Maruyama I; Arima S; Yamaguchi H; Okino H; Hamasaki S; Nomoto K; Atsuchi Y; Tahara M; Tanaka H
    J Cardiol; 1990; 20(4):849-59. PubMed ID: 2151948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.